JP2022535527A5 - - Google Patents
Info
- Publication number
- JP2022535527A5 JP2022535527A5 JP2021571613A JP2021571613A JP2022535527A5 JP 2022535527 A5 JP2022535527 A5 JP 2022535527A5 JP 2021571613 A JP2021571613 A JP 2021571613A JP 2021571613 A JP2021571613 A JP 2021571613A JP 2022535527 A5 JP2022535527 A5 JP 2022535527A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- use according
- antibody
- patient
- adc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025129110A JP2025172753A (ja) | 2019-06-04 | 2025-08-01 | 自己免疫疾患を治療するための方法および組成物 |
Applications Claiming Priority (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962857232P | 2019-06-04 | 2019-06-04 | |
| US62/857,232 | 2019-06-04 | ||
| US201962863141P | 2019-06-18 | 2019-06-18 | |
| US62/863,141 | 2019-06-18 | ||
| US201962882310P | 2019-08-02 | 2019-08-02 | |
| US62/882,310 | 2019-08-02 | ||
| US201962933279P | 2019-11-08 | 2019-11-08 | |
| US62/933,279 | 2019-11-08 | ||
| US201962944988P | 2019-12-06 | 2019-12-06 | |
| US62/944,988 | 2019-12-06 | ||
| US202062968870P | 2020-01-31 | 2020-01-31 | |
| US62/968,870 | 2020-01-31 | ||
| US202063030860P | 2020-05-27 | 2020-05-27 | |
| US63/030,860 | 2020-05-27 | ||
| PCT/US2020/036177 WO2020247670A1 (en) | 2019-06-04 | 2020-06-04 | Methods and compositions for treating autoimmune diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025129110A Division JP2025172753A (ja) | 2019-06-04 | 2025-08-01 | 自己免疫疾患を治療するための方法および組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022535527A JP2022535527A (ja) | 2022-08-09 |
| JP2022535527A5 true JP2022535527A5 (enExample) | 2023-06-23 |
Family
ID=73652045
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021571613A Pending JP2022535527A (ja) | 2019-06-04 | 2020-06-04 | 自己免疫疾患を治療するための方法および組成物 |
| JP2025129110A Pending JP2025172753A (ja) | 2019-06-04 | 2025-08-01 | 自己免疫疾患を治療するための方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025129110A Pending JP2025172753A (ja) | 2019-06-04 | 2025-08-01 | 自己免疫疾患を治療するための方法および組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US12403200B2 (enExample) |
| EP (1) | EP3980066A4 (enExample) |
| JP (2) | JP2022535527A (enExample) |
| KR (1) | KR20220016922A (enExample) |
| CN (2) | CN121796623A (enExample) |
| AU (1) | AU2020289360A1 (enExample) |
| BR (1) | BR112021024328A2 (enExample) |
| CA (1) | CA3140180A1 (enExample) |
| IL (1) | IL288563A (enExample) |
| MX (1) | MX2021014729A (enExample) |
| SG (1) | SG11202113331QA (enExample) |
| WO (1) | WO2020247670A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019374055B2 (en) * | 2018-10-30 | 2026-06-11 | Regeneron Pharmaceuticals, Inc. | Methods for allogeneic hematopoietic stem cell transplantation |
| JP2024500189A (ja) * | 2020-12-21 | 2024-01-04 | アロジーン セラピューティクス，インコーポレイテッド | プロテアーゼ活性化ｃｄ４５ゲートｃａｒ |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7265212B2 (en) * | 2001-12-03 | 2007-09-04 | Amgen Fremont Inc. | Anti-CD45RB antibodies |
| CA3014224C (en) * | 2009-02-05 | 2022-05-24 | Immunogen, Inc. | Condensed benzodiazepine-indoline derivatives and processes to prepare said derivatives |
| US9567340B2 (en) * | 2012-12-21 | 2017-02-14 | Medimmune Limited | Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases |
| US20170226209A1 (en) * | 2014-08-01 | 2017-08-10 | INSERM (Institut National de la Santé et de la Recherche Médicale) | An anti-cd45rc antibody for use as drug |
| DK3268047T3 (da) * | 2015-03-09 | 2024-01-02 | Heidelberg Pharma Res Gmbh | Amatoxin/antistof-konjugater |
| HK1256681A1 (zh) * | 2015-04-06 | 2019-10-04 | President And Fellows Of Harvard College | 用於非清髓性预处理的组合物和方法 |
| EP3222292A1 (en) * | 2016-03-03 | 2017-09-27 | Heidelberg Pharma GmbH | Amanitin conjugates |
| CN109641051A (zh) * | 2016-06-17 | 2019-04-16 | 美真达治疗公司 | 用于耗尽细胞的组合物和方法 |
| CN117653740A (zh) * | 2016-12-21 | 2024-03-08 | 诺华股份有限公司 | 用于消融造血干细胞的抗体药物缀合物 |
| EP3700568A4 (en) * | 2017-10-24 | 2021-11-10 | Magenta Therapeutics, Inc. | COMPOSITIONS AND METHODS FOR DEPLOYING CD117 + CELLS |
-
2020
- 2020-06-04 AU AU2020289360A patent/AU2020289360A1/en active Pending
- 2020-06-04 JP JP2021571613A patent/JP2022535527A/ja active Pending
- 2020-06-04 CA CA3140180A patent/CA3140180A1/en active Pending
- 2020-06-04 MX MX2021014729A patent/MX2021014729A/es unknown
- 2020-06-04 CN CN202511717645.1A patent/CN121796623A/zh active Pending
- 2020-06-04 KR KR1020217043420A patent/KR20220016922A/ko active Pending
- 2020-06-04 CN CN202080055620.9A patent/CN114173820B/zh active Active
- 2020-06-04 WO PCT/US2020/036177 patent/WO2020247670A1/en not_active Ceased
- 2020-06-04 SG SG11202113331QA patent/SG11202113331QA/en unknown
- 2020-06-04 EP EP20819317.7A patent/EP3980066A4/en active Pending
- 2020-06-04 BR BR112021024328A patent/BR112021024328A2/pt not_active IP Right Cessation
-
2021
- 2021-11-30 IL IL288563A patent/IL288563A/en unknown
- 2021-12-03 US US17/457,583 patent/US12403200B2/en active Active
-
2025
- 2025-08-01 JP JP2025129110A patent/JP2025172753A/ja active Pending
- 2025-08-27 US US19/312,214 patent/US20260069706A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019522680A5 (enExample) | ||
| JP7791923B2 (ja) | Ｃｄ５＋細胞の枯渇のための組成物および方法 | |
| CN113710277B (zh) | 一种负载双毒素的抗体药物偶联物及其应用 | |
| JP2022106807A (ja) | Ｃｄ１１７＋細胞を枯渇させるための組成物及び方法 | |
| TWI827590B (zh) | 稠和雙環C5aR拮抗劑之前藥 | |
| ES2274865T3 (es) | Anticuerpos recombinantes para la interleuquina-1 beta humana. | |
| US20220175951A1 (en) | Anti-CD45 Antibody Drug Conjugates and Uses Thereof | |
| CN100374457C (zh) | 抗il-6抗体、组合物、方法和用途 | |
| JP2020506176A5 (enExample) | ||
| AU2020205851B2 (en) | Conjugate comprising ligand, spacer, peptide linker, and biomolecule | |
| AU2019403404B2 (en) | Rifamycin analogs and antibody-drug conjugates thereof | |
| ES2774422T3 (es) | Anticuerpos para IL-21 | |
| JP6161592B2 (ja) | オーリスタチンチラミンリン酸塩およびオーリスタチンアミノキノリン誘導体ならびにそのプロドラッグ | |
| KR20200108002A (ko) | 스테로이드 및 이의 항체-접합체 | |
| RU2010153580A (ru) | Иммуноглобулины с двумя вариабельными доменами и их применение | |
| EA031044B1 (ru) | Человеческие антитела к онкостатину м и способы их применения | |
| BR112019012483A2 (pt) | conjugados de fármaco de anticorpo para ablar células-tronco hematopoiéticas | |
| ES3054393T3 (en) | Thienopyrrole compounds | |
| JP2022529726A5 (enExample) | ||
| BRPI0915667B1 (pt) | ligante, fragmentos scfv e fab, anticorpo, composição farmacêutica, ácido nucleico, molécula de ácido nucleico, vetor, célula hospedeira, método para produção do ligante, ligante, composição farmacêutica, método de detecção do antiligante em uma amostra biológica e kit de imunoensaio para detecção do antiligante em uma amostra biológica | |
| EP3958899A2 (en) | Anti-cd117 antibody-drug conjugates and uses thereof | |
| WO2021195401A1 (en) | Technologies for preventing or treating infections | |
| JP2022529727A5 (enExample) | ||
| Mathy et al. | Autoantibody to ribosomes and systemic lupus erythematosus | |
| JP2021511333A5 (enExample) |